What Happened?
Cambridge, MA-based Merus Appointed Harry Shuman as Chief Accounting Officer (CAO)
About the Company
Merus is developing best-in-class therapeutics to treat and potentially cure cancer patients. Our most advanced development programs use the Biclonics® format. Biclonics® are capable of simultaneously attacking tumors in multiple ways. For example by activating the immune system to kill tumor cells and directly inhibiting tumor cell growth and survival pathways.
About the Person
Harry Shuman is Chief Accounting Officer (CAO) at Merus. Previously, Harry held various senior HR leadership roles in the industry.
Info Source
News
Short Profile